Furthermore, de Menezes et al. found that exosomes expressing neuroinflammatory markers such as CD14, CD16, CD192, CD195, and GFAP are significantly associated with cognitive impairment severity (127). The gene discussed is CCR5; the disease is Cognitive impairment.